Sellas Life Sciences

SELLAS™ Life Sciences Appoints Former Barclays Biotechnology Research Analyst as Chief Business and Strategy Officer

–Seasoned Executive with Significant Healthcare Equity Markets and Cancer Research Expertise– ZUG, Switzerland and NEW YORK, NY, October 19, 2016 /PRNewswire/ — SELLAS Life Sciences Group (SELLAS or the Company), a late-stage biopharmaceutical company focused on the...
Read More →

SELLAS™ Life Sciences Announces Positive Interim Phase II Results from its WT1 Immunotherapeutic Anti-cancer Treatment in Multiple Myeloma Patients

Data Indicates Meaningful Clinical Benefit in High-risk Multiple Myeloma Patients ZUG, Switzerland and NEW YORK, NY, October 13, 2016 /PRNewswire/ — SELLAS Life Sciences Group (SELLAS or the Company), a late-stage biopharmaceutical company focused on the development of novel...
Read More →